RE:RE:Why i am not accumulatingBeanie28 wrote:
go away
Ya - I've heard it all before.
No one knows which way this goes but the odds are on it going up in the near-term.
Cash in the bank means we are in a stronger position - for negotiating and as a company.
If I'm an institutional investor and I look at this balance sheet ... much stronger now.
Keep the exciting news flowing (still lots availabe) and we're making our way to a US exchange.
Remember ... keep the list in mind ...
1. P3 design updates (including all pre-P3 animal study results)
2. FDA meeting
3. -352 updates
4. -340 updates (could be related to a COvID update as well)
5. fast iteration drug development updates (betting on an Alzheimer's/Parkinsons or a brain cell drug carrier next)
6. US exchange
7. amagamation
8. collaborations (heck ... if drug development is going to improve ... might as well find partners to help push some of these new drugs to the finish line faster - some with lots of cash - that collaboration could end up being a take-out partner one day.
9. partnerships
10. sale of Citagenix
11. all the others I missed on this list
So many possible angles and I wouldn't bet that we stand still ... not with cash in the bank and a technical advantage in "fast iterations" for gaseous mediator development. Kings of a whole new field of medicine ???????
Cheers All !